Key result
Elevated IL-6, IL-10, and CRP alongside lower RGM-A are linked to post-stroke pneumonia.
Why the study?
Ischemic stroke-associated pneumonia is a leading cause of mortality driven by peripheral immune imbalance, but clinical markers of immunosuppression associated with pneumonia after stroke have not been systematically evaluated.
Are peripheral immunosuppression markers associated with the development of pneumonia following ischemic stroke?
Systematic Review (n=1,833)
Are peripheral immunosuppression markers associated with the development of pneumonia following ischemic stroke?
Answers are grounded in this paper and cite their sources.
Elevated IL-6, IL-10, and CRP, along with reduced RGM-A, are associated with post-stroke pneumonia, highlighting the role of immune dysregulation in its pathophysiology.
Introduction Ischemic stroke (IS)-associated pneumonia is a leading cause of mortality after stroke, driven by peripheral immune imbalance. This systematic review evaluates immunosuppression markers associated with pneumonia following IS in clinical studies.Methods Following PRISMA guidelines, we searched PubMed/MEDLINE, EMBASE, and LILACS databases until March 2024. Inclusion criteria comprised clinical studies assessing IS-related immunosuppression and pneumonia, excluding in vitro and animal studies. Study quality was assessed using the Newcastle-Ottawa Scale.Results A total of 32 studies met the inclusion criteria, analyzing 1,833 post-stroke patients. Findings indicate that increased interleukin-6 (IL-6), interleukin-10 (IL-10), and C-reactive protein (CRP) levels, alongside decreased repulsive guidance molecule A (RGM-A), are early indicators of post-stroke pneumonia. Meta-analysis was not conducted due to heterogeneity in study methodologies and populations.Conclusions Elevated IL-6, IL-10, and CRP levels, along with reduced RGM-A, are associated with post-stroke pneumonia, emphasizing the role of immune dysregulation in its pathophysiology. Despite promising findings, further studies with standardized detection techniques are needed to enhance diagnostic accuracy and improve patient prognosis. The variability in study methodologies presents a limitation to drawing definitive conclusions.Registration: PROSPERO CRD42024543108.
No takes yet. Share an insight, caveat, or question.
Mello et al. (2025) conducted a systematic review in Ischemic stroke-associated pneumonia (n=1,833). Peripheral immunodepression markers (IL-6, IL-10, CRP, RGM-A) was evaluated on Post-stroke pneumonia. Elevated IL-6, IL-10, and CRP levels, alongside decreased RGM-A, were identified as early indicators associated with post-stroke pneumonia in a systematic review of 1,833 patients.
Synapse has enriched 10 related papers. Consider them for comparative context: